Filing Details
- Accession Number:
- 0001203311-12-000016
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-03-20 19:19:22
- Reporting Period:
- 2012-03-16
- Filing Date:
- 2012-03-20
- Accepted Time:
- 2012-03-20 19:19:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1060736 | Seattle Genetics Inc | SGEN | Biological Products, (No Disgnostic Substances) (2836) | 911874389 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1393945 | C Thomas Reynolds | 21823 30Th Drive Se Bothell WA 98021 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-03-16 | 2,300 | $8.24 | 33,373 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-03-16 | 2,300 | $19.75 | 31,073 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2012-03-19 | 37,700 | $8.24 | 68,773 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-03-19 | 37,700 | $19.75 | 31,073 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2012-03-16 | 2,300 | $0.00 | 2,300 | $8.24 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2012-03-19 | 37,700 | $0.00 | 37,700 | $8.24 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 118,649 | 2017-04-02 | No | 4 | M | Direct | |
| 80,949 | 2017-04-02 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Reynolds on November 8, 2011.
- Amount of securities beneficially owned following reported transactions includes 27,886 Restricted Stock Units subject to vesting.
- Shares shall vest at a rate of 25% on 3/19/07 and monthly thereafter until all the shares are fully vested on 3/19/11.
Billionaire Hedge Funds
